Longevity Weekly — April 1, 2026

Here's everything that happened in longevity sciencethis week— covering research, industry, lifestyle science, and culture from March 25 to April 1, 2026. This week: a naked mole rat gene extends mouse lifespan, a daily multivitamin moves the biological clock, omega-3 stacking gets more evidence, and Aubrey de Grey's foundation pairs with Human Longevity Inc. to study the world's oldest people.

[New Study] March 25, 2026 · Stanford / Science

A study published in Science and highlighted by Stanford's Wu Tsai Neuro this week found that simple midlife behaviours — movement, sleep timing, and activity levels — are surprisingly strong predictors of lifespan. Using zebrafish (which age similarly to humans), researchers led by Claire Bedbrook and Ravi Nath found that fish destined for shorter lives were already sleeping more during the day and moving with less vigour by early midlife. Crucially, aging wasn't a gradual process — animals stayed stable for long periods before rapidly transitioning into a new biological stage, mirroring emerging evidence from human studies. The finding reinforces the practical value of wearables that track daily movement and sleep as longevity biomarkers.

Read more →

[Neurodegenerative] March 26, 2026 · ScienceDaily

Researchers discovered a cellular "overflow valve" mechanism whose disruption is linked to Parkinson's disease — adding to a growing body of evidence connecting aging biology directly to neurodegeneration. Understanding how cells regulate this valve could open new avenues for treatments that target the aging process itself as a risk factor for Parkinson's, rather than only addressing symptoms after diagnosis.

Read more →

[Molecular Biology] March 30, 2026 · Fight Aging!

This week's Fight Aging! newsletter highlighted research showing that RNASEK — the protein responsible for breaking down circular RNA — declines with age, allowing circular RNA to accumulate in cells. Boosting RNASEK levels in model organisms extended lifespan and healthspan. The same newsletter also covered new findings on collagen gene expression as a dynamic regulator of aging in C. elegans, and the role of immune system changes in shaping gut microbiome composition as we age — all pointing to the value of targeting multiple molecular pathways simultaneously.

Read more →

[Epigenetics] March 2026 · Nature

A new analysis published in Nature shows that people whose biological markers change more slowly tend to live significantly longer — reinforcing the field's shift from calendar age to biological rate of change as the meaningful metric.

➤ Why it matters: How fast you age matters more than how old you are. This validates biological clocks as both research tools and potential clinical instruments — and puts pressure on interventions to demonstrate they actually slow the pace of change, not just move a number.

Read more →

[RCT] March 2026 · Harvard Gazette

A large randomised controlled trial found that taking a daily multivitamin slowed biological ageing by approximately four months over two years — a modest but statistically meaningful effect, particularly given the simplicity and low cost of the intervention.

➤ Why it matters: Not headline-grabbing — but important. Basic micronutrient sufficiency still matters. This is a reminder that the fundamentals aren't boring; they're foundational.

Read more →

[Molecular Biology] March 2026 · ScienceDaily

New research on polyamines — compounds that promote cellular health and have been linked to healthy ageing — shows they may also be connected to cancer growth when dysregulated. The same pathways that extend life can, under certain conditions, drive disease.

➤ Why it matters: A classic longevity paradox: the same biological mechanisms that support healthspan can become liabilities when dysregulated. It's a useful reminder that context and dosing matter enormously in longevity science.

Read more →

[Gene Therapy] March 2026 · SciTechDaily

Scientists successfully transferred a gene from naked mole rats — which live up to 10x longer than similar-sized rodents and rarely develop cancer — into mice, improving health markers and extending lifespan. Naked mole rats produce an unusually large form of hyaluronic acid that appears central to their exceptional longevity.

➤ Why it matters: Early-stage, but points toward gene-level interventions as a future frontier. Naked mole rats have been a model organism of interest for decades — this is one of the clearest demonstrations yet that their longevity mechanisms are transferable across species.

Read more →

[Population Study] March 2026 · UK Biobank

A large-scale analysis using UK Biobank data found that very small, consistent improvements — a few extra minutes of sleep, slightly better diet quality, modest increases in daily activity — can meaningfully extend lifespan when maintained over time.

➤ Why it matters: This directly challenges the "all or nothing" mindset that dominates wellness culture. Longevity is increasingly about aggregation of marginal gains — the same principle that transformed professional sport is now being confirmed at the population level.

[Clinical Trial] March 2026 · DO-HEALTH Trial

New results from the DO-HEALTH trial suggest that omega-3 supplementation — particularly when combined with vitamin D and regular strength training — can modestly but measurably slow biological ageing. The combination appeared more effective than any single intervention alone.

➤ Why it matters: Not a miracle intervention — but a good example of stacking simple, evidence-based inputs. The stacking effect matters: omega-3 alone does less than omega-3 + D + exercise together. This is the multi-pathway thinking that's increasingly guiding serious longevity protocols.

[Partnership] March 25, 2026 · PR Newswire

Human Longevity, Inc. (HLI) and the LEV Foundation — founded by longevity pioneer Aubrey de Grey — announced a major research collaboration this week to decode the biological drivers of exceptional longevity. The partnership will perform multi-omic analysis (genomics, proteomics) on blood samples from centenarians and supercentenarians, asking why some individuals age so much more slowly than others. Both Aubrey de Grey and Natalie Coles-de Grey are joining HLI's scientific advisory board. The collaboration represents one of the most direct applications of AI-driven longevity platforms to the genomes of the world's oldest people.

Read more →

[Clinical Trial Launch] March 26, 2026 · BioSpace

Swiss longevity biotech Timeline announced the launch of "CLARITY" — its 25th registered clinical trial and the largest brain aging study ever conducted on a finished supplement product. The trial studies the effects of Mitopure® (Urolithin A), Timeline's flagship mitophagy-stimulating ingredient, on brain health markers in aging adults. Alongside CLARITY, Timeline published a new clinical study on immune aging. The company has invested over $50M in research and holds 80+ global patents around Urolithin A, which supports mitochondrial recycling — a cellular process that declines with age.

Read more →

[Big Pharma + Longevity] Week of March 27, 2026

Fauna Bio announced this week that its obesity collaboration with Eli Lilly hit a key target designation milestone, triggering a payment under the pair's $494M deal. Fauna's Convergence AI platform studies hibernating mammals — animals that naturally preserve muscle mass during months of inactivity — to identify first-in-class drug targets for obesity and muscle loss. The designated target could inform a new approach to preventing the lean-mass loss that typically accompanies GLP-1 weight-loss drugs, a critical challenge in the longevity and metabolic health space. Lilly is rapidly establishing itself as the leading Big Pharma player in longevity-adjacent therapeutics.

Read more →

[Exhibition] March 2026 · Wellcome Collection

A new Wellcome Collection exhibition highlights a striking cultural disconnect: our collective desire to live longer sits in uneasy tension with our discomfort — and often outright denial — of ageing itself. As science accelerates toward meaningful life extension, the cultural narrative hasn't caught up.

➤ Why it matters: Longevity isn't just biology — it's cultural. The technologies are advancing faster than our social frameworks for thinking about age, identity, and what a long life is actually for. This is one of the more underexplored dimensions of the longevity conversation.

April 8–9, 2026 · Berlin

Next week's congress in Berlin is centering on a major conceptual shift: aging as a failure of coordination between biological systems rather than simple cellular damage. Scientists will argue the next breakthrough may not be a molecule — it may be a new framework for understanding how living systems communicate as they age.

This week's evidence converges on something simple: done consistently, small improvements compound into meaningful impact. Not exciting — but effective. The UK Biobank data and DO-HEALTH trial both point here.